Venous thromboembolism: Contemporary diagnostic and therapeutic aspects

Vasa - Journal of Vascular Diseases

Volumn 37, Issue 3, 2008, Pages 211-226

  Bounameaux, Henri ^a   Righini, M ^a   Perrier, A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Anticoagulant treatment; Clinical probability; Helical CT; Pulmonary embolism; Ultrasonography

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 10A INHIBITOR; D DIMER; DABIGATRAN; DALTEPARIN; ENOXAPARIN; FLUINDIONE; FONDAPARINUX; FRAXIFORTE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PHENPROCOUMON; PLACEBO; RIVAROXABAN; THROMBIN INHIBITOR; TINZAPARIN; UNCLASSIFIED DRUG; WARFARIN; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; VITAMIN K GROUP;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; CLINICAL TRIAL; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG SAFETY; ECHOGRAPHY; ELDERLY CARE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INVASIVE MEASUREMENT; PATIENT COMPLIANCE; PATIENT SAFETY; PREDICTION; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SKIN NECROSIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; AGE; BLOOD; BLOOD CLOTTING; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG EFFECT; HEALTH SURVEY; METHODOLOGY; ORAL DRUG ADMINISTRATION; PREDICTION AND FORECASTING; RISK ASSESSMENT;

ADMINISTRATION, ORAL; AGE FACTORS; ANTICOAGULANTS; BIOLOGICAL MARKERS; BLOOD COAGULATION; DRUG ADMINISTRATION SCHEDULE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEALTH STATUS INDICATORS; HUMANS; PREDICTIVE VALUE OF TESTS; PULMONARY EMBOLISM; RISK ASSESSMENT; TOMOGRAPHY, SPIRAL COMPUTED; ULTRASONOGRAPHY; VENOUS THROMBOEMBOLISM; VITAMIN K;

EID: 63049097233     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.37.3.211     Document Type: Review

References (80)

1. Agnelli G, Prandoni P, Santamaria MG, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med 2001; 345: 165-9.
2. Anderson DR, Kovacs MJ, Dennie C, Kovacs G, Stiell I, Dreyer J, McCarron B, Pleasance S, Burton E, Cartier Y, Wells PS. Use of spiral computed tomography contrast angiography and ultrasonography to exclude the diagnosis of pulmonary embolism in the emergency department. J Emerg Med 2005; 29: 399-404.
3. Anderson DR, Kahn SR, Rodger MA, Kovacs MJ, Morris T, Hirsch A, Lang E, Stiell I, Kovacs G, Dreyer J, Dennie C, Cartier Y, Barnes D, Burton E, Pleasance S, Skedgel C, O'Rourke K, Wells PS. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. JAMA 2007; 298: 2743-53.
4. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960; 1: 1309-12.
5. Beer JH, Burger M, Gretener S, Bernard-Bagattini S, Bounameaux H. Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients. J Thromb Haemost 2003; 1: 186-7.
6. Blum A, Bellou A, Guillemin F, Douek P, Laprevote-Heully MC, Wahl D. Performance of magnetic resonance angiography in suspected acute pulmonary embolism. Thromb Haemost 2005; 93: 503-11.
7. Bosson JL, Barro C, Satger B, Carpentier PH, Polack B, Pernod G. Quantitative high D-dimer value is predictive of pulmonary embolism occurrence independently of clinical score in a well-defined low risk factor population. J Thromb Haemost 2005; 3: 93-9.
8. Bounameaux H, de Moerloose P, Sarasin FP. Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbs. Blood Coagul Fibrinol 1996; 7: 507-14.
9. Bounameaux H, de Moerloose P. Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No. J Thromb Haemost 2004; 2: 551-4.
10. Brandjes DP, Heijboer H, Büller HR, de Rijk M, Jagt H, ten Cate JW. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 1992; 327: 1485-9.
11. Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob GE, van den Berg-Segers AE, Cariou R, Leeuwenkamp O, Lensing AW and the Matisse Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349: 1695-702. Erratum in: N Engl J Med. 2004; 350: 423.
12. Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease. Chest 2004; 126: 401S-28S.
13. Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob GE, Segers AE, Cariou R, Leeuwenkamp O, Lensing AW and the Matisse Investigators. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 2004; 140: 867-73.
14. Chagnon I, Bounameaux H, Aujesky D, Roy PM, Gourdier AL, Cornuz J, Perneger T, Perrier A. Comparison of two clinical prediction rules and implicit assessment for suspected pulmonary embolism. Am J Med 2002; 113: 269-75.
15. CHRISTOPHER Study Investigators. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006; 295: 172-9.
16. Couturaud F, Parent F, Meyer G, Girard P, Le Gal G, Musset D, Simonneau G, Mottier D, Leroyer C. Effect of age on the performance of a diagnostic strategy based on clinical probability, spiral computed tomography and venous compression ultrasonography.the ESSEP Study. Thromb Haemost 2005; 93: 605-9.
17. de Groot MR, van Marwijk Kooy M, Pouwels JG, Engelage AH, Kuipers BF, Buller HR. The use of a rapid D-dimer blood test in the diagnostic work-up for pulmonary embolism: a management study. Thromb Haemost 1999; 82: 1588-92.
18. de Monye W,Huisman MV, Pattynama PM. Observer dependency of the SimpliRed D-dimer assay in 81 consecutive patients with suspected pulmonary embolism. Thromb Res 1999; 96: 293-8.
19. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279: 458-62.
20. Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 2000; 160: 3431-6.
21. Elias A, Cazanave A, Elias M, Chabbert V, Juchet H, Paradis H, Carriere P, Nguyen F, Didier A, Galinier M, Colin C, Lauque D, Joffre F, Rousseau H. Diagnostic management of pulmonary embolism using clinical assessment, plasma D-dimer assay, complete lower limb venous ultrasound and helical computed tomography of pulmonary arteries. A multicentre clinical outcome study. Thromb Haemost 2005; 93: 982-8.
22. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich, MW, Radford MJ. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006; 151: 713-9.
23. Ghanima W, Almaas V, Aballi S, Dorje C, Nielssen BE, Holmen LO, Almaas R, Abdelnoor M, Sandset PM. Management of suspected pulmonary embolism (PE) by D-dimer and multi-slice computed tomography in outpatients: an outcome study. J Thromb Haemost 2005; 3: 1926-32.
24. Ghaye B, Szapiro D, Mastora I, Delannoy V, Duhamel A, Remy J, Remy-Jardin M. Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis? Radiology 2001; 219: 629-36.
25. Girard P, Sanchez O, Leroyer C, Musset D,Meyer G, Stern JB, Parent F and Evaluation du scanner Spiralé dans l'Embolie pulmonaire Study Group. Deep venous thrombosis in patients with acute pulmonary embolism: prevalence, risk factors, and clinical significance. Chest 2005; 128: 1593-600.
26. Halkin H, Lubetsky A. Warfarin dose requirement and CYP2C9 polymorphisms. Lancet 1999; 353: 1972-3.
27. Hildner FJ, Ormond RS. Accuracy of the clinical diagnosis of pulmonary embolism. JAMA 1967; 202: 115-8.
28. Hommes DW, Bura A, Mazzolai L, Büller HR, ten Cate JW. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis. Ann Intern Med 1992; 116: 279-84.
29. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007; 115: 2689-96.
30. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-7. Erratum in N Engl J Med 1999; 341: 298.
31. Kearon C, Ginsberg JS, Kovacs MJ, et al. Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349: 631.
32. Klok FA, Kruisman E, Spaan J, Nijkeuter M, Righini M, Aujesky D, Roy PM, Perrier A, Le Gal G, Huisman MV. Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism. J Thromb Haemost 2008; 6: 40-4.
33. Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van de Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 1996; 334: 682-7. Erratum in: N Engl J Med 1997; 337: 1251.
34. Kruip MJ, Slob MJ, Schijen JH, van der Heul C, Buller HR. Use of a clinical decision rule in combination with D-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism: a prospective management study. Arch Intern Med 2002; 162: 1631-5.
35. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 1993; 95: 315-28.
36. Leclercq MGL, Kruip MJHA, Mac Gillavry MR, Van Marwijk Kooy M, Buller HR. Observer variability in the assessment of clinical probability in patients with suspected pulmonary embolism. J Thromb Haemost 2004; 2: 1204-6.
37. Leizorovicz A, Simonneau G, Decousus H, Boissel JP. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ 1994; 309: 299-304.
38. Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H, Perrier A. Prediction of pulmonary embolism in emergency patients: the revised Geneva score. Ann Intern Med 2006; 144: 165-71.
39. Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, De Maeseneer M, Hermsen JT, Trienekens PH, Hoogsteden H, Pattynama PM. Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score, a sensitive quantitative D-dimer test and noninvasive diagnostic tools. Semin Vasc Med 2005; 5: 351-64.
40. Musset D, Parent F, Meyer G, Maitre S, Girard P, Leroyer C, Revel MP, Carette MF, Laurent M, Charbonnier B, Laurent F, Mal H, Nonent M, Lancar R, Grenier P, Simonneau G. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet 2002; 360: 1914-20.
41. Nendaz MR, Bandelier P, Aujesky D, Cornuz J, Roy PM, Bounameaux H, Perrier A. Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome. Thromb Haemost 2004; 91: 1232-6.
42. Palareti G, Cosmi B. Predicting the risk of recurrence of venous thromboembolism. Curr Opin Hematol 2004; 11: 192-7.
43. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pettacini C, Testa S, Lensing AW, Tripodi A, for the PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006; 355: 1780-1789. Erratum in N Engl J Med 2006; 355: 2797.
44. Perrier A, Desmarais S, Miron MJ, de Moerloose P, Lepage R, Slosman D, Didier D, Unger PF, Patenaude JV, Bounameaux H. Noninvasive diagnosis of venous thromboembolism in outpatients. Lancet 1999; 353: 190-5.
45. Perrier A, Miron MJ, Desmarais S, de Moerloose P, Slosman D, Didier D, Unger PF, Junod A, Patenaude JV, Bounameaux H. Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: Is it a valid option in patients with normal results of lower- limb venous compression ultrasonography? Arch Intern Med 2000; 160: 512-6.
46. Perrier A, Howarth N, Didier D, Loubeyre P, Unger PF, de Moerloose P, Slosman D, Junod A, Bounameaux H. Performances of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med 2001; 135: 88-97.
47. Perrier A, Bounameaux H. Cost-effective diagnosis of deep vein thrombosis and pulmonary embolism. Thromb Haemost 2001; 86: 475-87.
48. Perrier A, Roy PM, Aujesky D, Chagnon I, Howarth N, Gourdier AL, Leftheriotis G, Bargouth G, Cornuz J, Hayoz D, Bounameaux H. Diagnosing pulmonary embolism with clinical assessment, D-dimer, venous ultrasound and helical computed tomography: a multicenter management study. Am J Med 2004; 116: 291-9.
49. Perrier A, Roy PM, Sanchez O, Le Gal G, Meyer G, Gourdier AL, Furber A, Revel MP, Howarth N, Davido A, Bounameaux H. Multidetector-row computed tomography in suspected pulmonary embolism.N Engl J Med 2005; 352: 1760-8.
50. Pinède L, Cucherat M, Duhaut P, Ninet J, Pasquier J, Boissel JP. Comparison of long versus short duration of oral anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized controlled trials. J Intern Med 2000; 247: 553-62.
51. PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990; 263: 2753-9.
52. Prandoni P, Lensing WA, Prins MH, et al. Residual thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002; 137: 955-60.
53. Quiroz R, Kucher N, Zou KH, Kipfmuller F, Costello P, Goldhaber SZ, Schoepf UJ. Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA 2005; 293: 2012-7.
54. Rémy-Jardin M, Rémy J, Wattinne L, Giraud F. Central pulmonary tromboembolism: diagnosis with spiral volumetric CT with the single-breath-hols technique. Comparison with pulmonary angiography. Radiology 1992; 185: 381-7.
55. Research Committee of the British Thoracic Society. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003; 58: 470-84.
56. Ridker, PM, Goldhaber SZ, Danielson E, et al. Long-term, low-intensity warfarin for the prevention of recurrent venous thromboembolism: A randomized. Double-blind, placebo-controlled trial. N Engl J Med 2003; 348: 1425-34.
57. Ridker PM. Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism: yes. J Thromb Haemost 2004; 2: 1034-7.
58. Righini M, Le Gal G, Perrier A, Bounameaux H. The challenge of diagnosing pulmonary embolism in elderly patients: influence of age on commonly used diagnostic tests and strategies. J Am Geriatr Soc 2005; 53: 1039-45.
59. Righini M, Paris S, Le Gal G, Laroche JP, Perrier A, Bounameaux H. Clinical relevance of distal deep vein thrombosis. Review of literature data. Thromb Haemost 2006; 95: 56-64.
60. Righini M, Le Gal G, Aujesky D, Roy PM, Sanchez O, Verschuren F, Rutschmann O, Nonent M, Cornuz J, Thys F, Petit Le Manach C, Revel PM, Poletti PA, Meyer G, Mottier D, Perneger T, Bounameaux H, Perrier A. Diagnosis of pulmonary embolism by multidetector computed tomography alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial. Lancet 2008; 371: 1343-52.
61. Rodger MA, Mase E, Stiell I, Howley HE,Wells PS. The interobserver reliability of pretest probability assessment in patients with suspected pulmonary embolism. Thromb Res 2005; 116: 101-7.
62. Roy PM, Colombet I, Durieux P, Chatellier G, Sors H, Meyer G. Systematic review and metaanalysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ 2005; 331: 259.
63. Roy PM, Meyer G, Vielle B, Le Gall C, Verschuren F, Carpentier F, Leveau P, Furber A and the EMDEPU Study Group. Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism. Ann Intern Med 2006; 144: 157-64.
64. Sarasin FP, Bounameaux H. Duration of oral anticoagulant therapy after proximal deep vein thrombosis: a decision analysis. Thromb Haemost 1994; 71: 286-91.
65. Sarasin FP, Bounameaux H. Decision analysis model of prolonged oral anticoagulant treatment in Factor V Leiden carriers with first episode of deep vein thrombosis BMJ 1998; 316: 95-9.
66. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P, Loogna E, Svensson E, Ljunberg B, Walter H. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661-5.
67. Schulman S, Granqvist S, Holmström M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Lärfars G, Leijd B, Linder O, Loogna E. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997; 336: 393-8.
68. Schwarz UI, Ritchie MD, Bradford Y, Li C, Dudek SM, Frye-Anderson A, Kim RB, Roden DM, Stein CM. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 2008; 358: 999-1008.
69. Sohne M, Kamphuisen PW, van Mierlo PJ, Buller HR. Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly in-and outpatients. Thromb Haemost 2005; 94: 206-10.
70. Simonneau G, Sors H, Charbonnier B, Page Y, Laaban JP, Azarian R, Laurent M, Hirsch JL, Ferrari E, Bosson JL, Mottier D, Beau B. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. N Engl J Med 1997; 337: 663-9.
71. Ten Wolde M, Hagen PJ, Macgillavry MR, Pollen IJ, Mairuhu ATA, Koopman MMW, Prins MH, Hoekstra OS, Brandjes DP, Postmus PE, Büller HR. Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study. J Thromb Haemost 2004; 2: 1110-7.
72. Torn M, Bollen WL, van der Meer FJ, va der Wall EE, Rosendaal FR. Risks of oral anticoagulant therapy with increasing age. Arch Intern Med 2005; 165: 1527-32.
73. van Beek EJ, Brouwerst EM, Song B, Stein PD, Oudkerk M. Clinical validity of a normal pulmonary angiogram in patients with suspected pulmonary embolism - a critical review. Clin Radiol 2001; 56: 838-42.
74. van Strijen MJ, De Monye W, Kieft GJ, Pattynama PM, Prins MH, Huisman MV. Accuracy of single-detector spiral CT in the diagnosis of pulmonary embolism: a prospective multicenter cohort study of consecutive patients with abnormal perfusion scintigraphy. J Thromb Haemost 2005; 3: 17-25.
75. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 311S-37S. Erratum in: Chest 2005; 127: 416.
76. Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med 2007; 356: 2653-5.
77. Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, Turpie AG, Bormanis J, Weitz J, Chamberlain M, Bowie D, Barnes D, Hirsh J. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83: 416-20.
78. Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann Intern Med 2001; 135: 98-107.
79. Wicki J, Perrier A, Perneger TV, Bounameaux H, Junod AF. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000; 84: 548-52.
80. Wicki J, Perneger TV, Junod A, Bounameaux H, Perrier A. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med 2001; 161: 92-7.